Literature DB >> 13905056

New approaches in the study of cardiovascular disease: aldosterone, renin, hypertension and juxtaglomerular cells.

W S HARTROFT, P M HARTROFT.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX/physiology; ALDOSTERONE/metabolism; CARDIOVASCULAR DISEASES/physiology; KIDNEY/physiology

Mesh:

Substances:

Year:  1961        PMID: 13905056

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


× No keyword cloud information.
  8 in total

1.  REDUCED VASCULAR RESPONSE TO ANGIOTENSIN II IN SECONDARY HYPERALDOSTERONISM.

Authors:  C I JOHNSTON; A D JOSE
Journal:  J Clin Invest       Date:  1963-09       Impact factor: 14.808

2.  [CONTRIBUTION TO THE COMPARATIVE MORPHOLOGY OF EPITHELOID CELLS IN THE KIDNEY ARTERIOLES WITH SPECIAL REFERENCE TO THE EPITHELOID CELLS IN THE KIDNEYS OF SALT WATER].

Authors:  A BOHLE; F WALVIG
Journal:  Klin Wochenschr       Date:  1964-05-01

3.  CORRELATION OF ENZYMATIC ACTIVITY OF THE JUXTAGLOMERULAR COMPLEX WITH RENIN CONTENT IN RENAL HYPERTENSIVE RATS.

Authors:  R HESS; D REGOLI
Journal:  Br J Exp Pathol       Date:  1964-12

4.  SIGNIFICANCE OF BLOOD ANGIOTENSIN LEVELS IN DIFFERENT EXPERIMENTAL CONDITIONS.

Authors:  O A SCORNIK; A C PALADINI
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

5.  The functional basis of acute renal failure.

Authors: 
Journal:  Can Med Assoc J       Date:  1967-05-20       Impact factor: 8.262

6.  Response of plasma renin activity during surgical stress.

Authors:  H Yogo; T Sasaki; T Yamaoka; T Naruse; Y Itasaka
Journal:  Jpn J Surg       Date:  1973-12

Review 7.  The nutritional aspects of hypertension and its reversibility.

Authors:  W S Hartroft
Journal:  Am J Public Health Nations Health       Date:  1966-03

8.  Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression.

Authors:  Jiqian Huang; Helmy M Siragy
Journal:  Endocrinology       Date:  2009-10-27       Impact factor: 4.736

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.